Hepatitis C Treatment Is Cost-effective For The US Prison Population
Friday, October 24, 2008 - 23:21
in Health & Medicine
Treating all US prisoners who have hepatitis C with the standard therapy of pegylated-interferon and ribavirin would be cost-effective, says a new study.